MC

530.3

+7.21%↑

SANES

6.712

+1.18%↑

BNP

79.15

+2.35%↑

DB1.DE

277.6

-4.01%↓

CABK

7.322

+1.02%↑

MC

530.3

+7.21%↑

SANES

6.712

+1.18%↑

BNP

79.15

+2.35%↑

DB1.DE

277.6

-4.01%↓

CABK

7.322

+1.02%↑

MC

530.3

+7.21%↑

SANES

6.712

+1.18%↑

BNP

79.15

+2.35%↑

DB1.DE

277.6

-4.01%↓

CABK

7.322

+1.02%↑

MC

530.3

+7.21%↑

SANES

6.712

+1.18%↑

BNP

79.15

+2.35%↑

DB1.DE

277.6

-4.01%↓

CABK

7.322

+1.02%↑

MC

530.3

+7.21%↑

SANES

6.712

+1.18%↑

BNP

79.15

+2.35%↑

DB1.DE

277.6

-4.01%↓

CABK

7.322

+1.02%↑

Search

Sartorius Stedim Biotech.

Open

BrancheFinanzen

198.35 -1.71

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

196.55

Max

201.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

75M

115M

Verkäufe

-6.7M

745M

KGV

Branchendurchschnitt

100.566

24.507

EPS

1.16

Dividendenrendite

0.33

Gewinnspanne

15.498

Angestellte

9,961

EBITDA

124M

256M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+18.09% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.33%

4.35%

Nächstes Ergebnis

22. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

4.2B

21B

Vorheriger Eröffnungskurs

200.06

Vorheriger Schlusskurs

198.35

Nachrichtenstimmung

By Acuity

34%

66%

93 / 540 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Sartorius Stedim Biotech. Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Mai 2025, 23:48 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11. Mai 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11. Mai 2025, 23:45 UTC

Market Talk

Oil Rises Amid Improved Market Mood -- Market Talk

11. Mai 2025, 23:38 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Aristocrat Has Significant Firepower for M&A -- Market Talk

11. Mai 2025, 23:36 UTC

Market Talk

Global Markets Uncertain About US-China Trade News -- Market Talk

11. Mai 2025, 23:35 UTC

Market Talk

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11. Mai 2025, 23:33 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11. Mai 2025, 23:32 UTC

Top News

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11. Mai 2025, 22:44 UTC

Market Talk

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11. Mai 2025, 22:33 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11. Mai 2025, 20:19 UTC

Top News

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11. Mai 2025, 16:00 UTC

Top News

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11. Mai 2025, 11:00 UTC

Top News

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11. Mai 2025, 08:00 UTC

Top News

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11. Mai 2025, 01:00 UTC

Top News

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11. Mai 2025, 01:00 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10. Mai 2025, 21:54 UTC

Top News

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10. Mai 2025, 17:12 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10. Mai 2025, 15:41 UTC

Top News

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10. Mai 2025, 12:00 UTC

Top News

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10. Mai 2025, 09:30 UTC

Top News

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10. Mai 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10. Mai 2025, 03:52 UTC

Top News

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9. Mai 2025, 23:51 UTC

Akquisitionen, Fusionen, Übernahmen

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9. Mai 2025, 22:06 UTC

Market Talk

Arm Holdings Remains a Strong Growth Story -- Market Talk

9. Mai 2025, 21:37 UTC

Top News

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9. Mai 2025, 21:10 UTC

Top News

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9. Mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. Mai 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

9. Mai 2025, 20:42 UTC

Top News

Stocks Get a Break From Trade Chaos -- WSJ

Peer-Vergleich

Kursveränderung

Sartorius Stedim Biotech. Prognose

Kursziel

By TipRanks

18.09% Vorteil

12-Monats-Prognose

Durchschnitt 239.13 EUR  18.09%

Hoch 250 EUR

Tief 210 EUR

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sartorius Stedim Biotech. – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

8 ratings

5

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

202.7 / 211.7Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

93 / 540 Ranking in Finanzen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.